MARINA-OLE Trademark

Trademark Overview


On Thursday, February 17, 2022, a trademark application was filed for MARINA-OLE with the United States Patent and Trademark Office. The USPTO has given the MARINA-OLE trademark a serial number of 97272570. The federal status of this trademark filing is REGISTERED as of Tuesday, June 11, 2024. This trademark is owned by Avidity Biosciences, Inc.. The MARINA-OLE trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

oligonucleotide-conjugate based therapies, oligonucleotide-antibody conjugate based therapies, and oligonucleotide-antibody fragment conjugate based therapies for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders

providing medical and scientific research information in the fields of pharmaceuticals and biotechnology
marina-ole

General Information


Serial Number97272570
Word MarkMARINA-OLE
Filing DateThursday, February 17, 2022
Status700 - REGISTERED
Status DateTuesday, June 11, 2024
Registration Number7414532
Registration DateTuesday, June 11, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 28, 2022

Trademark Statements


Goods and Servicesoligonucleotide-conjugate based therapies, oligonucleotide-antibody conjugate based therapies, and oligonucleotide-antibody fragment conjugate based therapies for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Goods and Servicesproviding medical and scientific research information in the fields of pharmaceuticals and biotechnology

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 23, 2022
Primary Code005
First Use Anywhere DateTuesday, August 2, 2022
First Use In Commerce DateTuesday, August 2, 2022

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, February 23, 2022
Primary Code042
First Use Anywhere DateTuesday, August 2, 2022
First Use In Commerce DateTuesday, August 2, 2022

Trademark Owner History


Party NameAvidity Biosciences, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Party NameAvidity Biosciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Party NameAvidity Biosciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events


Event DateEvent Description
Monday, February 21, 2022NEW APPLICATION ENTERED
Wednesday, February 23, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 21, 2022ASSIGNED TO EXAMINER
Friday, April 22, 2022NON-FINAL ACTION WRITTEN
Friday, April 22, 2022NON-FINAL ACTION E-MAILED
Friday, April 22, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, May 11, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, May 11, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, May 11, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, May 19, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 8, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 28, 2022PUBLISHED FOR OPPOSITION
Tuesday, June 28, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 23, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, February 13, 2023SOU TEAS EXTENSION RECEIVED
Monday, February 13, 2023SOU EXTENSION 1 FILED
Monday, February 13, 2023SOU EXTENSION 1 GRANTED
Wednesday, February 15, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 10, 2023TEAS STATEMENT OF USE RECEIVED
Thursday, August 10, 2023USE AMENDMENT FILED
Friday, August 4, 2023SOU TEAS EXTENSION RECEIVED
Friday, August 4, 2023SOU EXTENSION 2 FILED
Friday, August 4, 2023SOU EXTENSION 2 GRANTED
Tuesday, August 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, August 20, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, December 4, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, August 20, 2023STATEMENT OF USE PROCESSING COMPLETE
Thursday, September 21, 2023SU - NON-FINAL ACTION - WRITTEN
Thursday, September 21, 2023NON-FINAL ACTION E-MAILED
Thursday, September 21, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 23, 2024ASSIGNED TO LIE
Tuesday, April 23, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 7, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, May 7, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, June 11, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, June 11, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, April 23, 2024TEAS/EMAIL CORRESPONDENCE ENTERED